GlassScriptPhysician profile
Marshall William Witt
NPI 1881470805
$2,606.94
in general payments reported to CMS, 2019-2025
17 companies · $2,122 in 2025
The $2,122 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $485 · 2025: $2,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,229 · Education: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,228.96 |
| Education | $377.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $581.49 | 2024-2025 | Adbry, Anzupgo |
| Janssen Biotech, INC. | $413.12 | 2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $302.24 | 2025 | |
| Lilly USA, LLC | $263.83 | 2024-2025 | Ebglyss, Taltz |
| Ucb, INC. | $241.97 | 2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $222.59 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $186.43 | 2025 | Sotyktu |
| Eli Lilly and Company | $99.00 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $51.55 | 2024 | Exparel, Iovera, Zilretta |
| Regeneron Healthcare Solutions, INC. | $50.44 | 2025 | Dupixent, Libtayo |
| Heron Therapeutics, INC. | $43.73 | 2024 | Zynrelef |
| Abbvie INC. | $34.79 | 2025 | |
| Pfizer INC. | $33.63 | 2025 | |
| Incyte Corporation | $28.22 | 2025 | Opzelura |
| Vertex Pharmaceuticals Incorporated | $20.93 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $18.98 | 2024 | Irrisept |
| Galderma Laboratories, L.P. | $14.00 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Witt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.